Kidney transplant drug switch: which works better?
Disease control
Ongoing
This study looks at kidney transplant patients who are already on standard anti-rejection drugs. It compares what happens when they switch to one of two other medications, RaparoBell or My-Rept. The goal is to see which drug better prevents organ rejection, graft loss, or death. …
Phase: PHASE4 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC